The FDA granted accelerated approval to telisotuzumab vedotin (Emrelis) for the treatment of adults with previously treated, ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...

Scientists have discovered how iron in lysosomes can induce ferroptosis, offering a new route to target treatment-resistant ...

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung cancer ... to promoting cancer growth and metastasis, can we stop ...

"Optune Lua is an innovative and urgently needed new approach for treating metastatic non-small cell lung cancer," said Joachim Aerts, M.D., a LUNAR investigator and Professor of Pulmonary ...

Key exclusion criteria included a history of severe immune-related adverse events from prior immune checkpoint inhibitor use, untreated or symptomatic central nervous system metastases, and a history ...

Compared to the other major kind of lung cancer, small cell lung ... has spread to regional lymph nodes (part of the immune system) and eventually distant organs, such as the liver, brain, or ...